bit.bio (@bitbio) 's Twitter Profile
bit.bio

@bitbio

Our mission is coding cells for novel cures.
Trade mark information bit.bio/trademarks

ID: 961170830972608512

linkhttp://www.bit.bio calendar_today07-02-2018 09:32:38

723 Tweet

1,1K Takipçi

556 Takip Edilen

bit.bio (@bitbio) 's Twitter Profile Photo

🎉 Exciting news! bit.bio is featured in the inaugural Sunday Times 100 Tech as a Biotech One to Watch! Honoured to be recognised for advancing access to cells for human health. 🙌 #Biotech #TechInnovation #SundayTimesTech100

🎉 Exciting news! <a href="/bitbio/">bit.bio</a> is featured in the inaugural Sunday Times 100 Tech as a Biotech One to Watch! Honoured to be recognised for advancing access to cells for human health. 🙌 #Biotech #TechInnovation #SundayTimesTech100
bit.bio (@bitbio) 's Twitter Profile Photo

Are you at #SLAS2025? Visit booth 851 to learn how #ioCells powered by opti-ox support drug discovery. 📍 Don’t miss: -5 scientific posters -Exhibitor Tutorial (28 Jan, 8:30am) feat. Charles River Labs, Bio Axion Healthindo, Sartorius & bit.bio Details: hubs.ly/Q0340Q-g0

bit.bio (@bitbio) 's Twitter Profile Photo

🚨 NEW ioCELLS ALERT! 🚨 Introducing ioTracker Cells for added visualisation functionality to opti-ox powered hiPSC-derived cells. First up: GFP ioMicroglia, for easy tracking & isolation in complex cultures. Learn more: hubs.ly/Q0342mrD0 #Neurodegeneration #ioCells

bit.bio (@bitbio) 's Twitter Profile Photo

Join us at #SLAS2025 today at 8:30 AM PST for our exhibitor tutorial showcasing real-world applications of #ioCells in #drugdiscovery. Not at SLAS? Access our posters featuring the NEW GFP ioMicroglia co-cultured with ioGlutamatergic Neurons: hubs.ly/Q034jPpx0

BioTechniques (@mybiotechniques) 's Twitter Profile Photo

In this interview from #SfN24, Tony Oosterveen bit.bio discusses how using their opti-ox technology, they developed a potential pain model that could help develop more effective drugs for pain hubs.ly/Q034JxYh0

In this interview from #SfN24, Tony Oosterveen <a href="/bitbio/">bit.bio</a> discusses how using their opti-ox technology, they developed a potential pain model that could help develop more effective drugs for pain hubs.ly/Q034JxYh0
bit.bio (@bitbio) 's Twitter Profile Photo

🚨 A new approach to pain relief. For the first time in 20 years, the #FDA has approved a new class of pain medication. JOURNAVX™ (suzetrigine) targets NaV1.8 in sensory neurons, offering a non-opioid option for acute pain. hubs.ly/Q035LBd-0

bit.bio (@bitbio) 's Twitter Profile Photo

Today is #InternationalDayOfWomenInScience! We recently had the privilege of working with the Women's Brain Foundation and CEO, Dr. Santuccione Chadha whose work is shaping precision medicine in neurology. Watch her TED Talk: hubs.ly/Q0367SgX0 antonella santuccione chadha Women's Brain Foundation

bit.bio (@bitbio) 's Twitter Profile Photo

Simple blood test could transform dementia research. A UK-wide trial is rolling out a blood test to detect early signs of dementia before symptoms appear, using blood-based markers of brain inflammation. hubs.ly/Q036KvkN0 Maura Malpetti Race Against Dementia Cambridge University

Simple blood test could transform dementia research.
A UK-wide trial is rolling out a blood test to detect early signs of dementia before symptoms appear, using blood-based markers of brain inflammation. 
hubs.ly/Q036KvkN0

<a href="/M_Malpetti/">Maura Malpetti</a> <a href="/racingdementia/">Race Against Dementia</a> <a href="/Cambridge_Uni/">Cambridge University</a>
bit.bio (@bitbio) 's Twitter Profile Photo

Today on #RareDiseaseDay, we are reminded of the profound impact our work can have on real lives. It’s a powerful reason behind everything we do. Thank you, #Everlum, for this beautiful reminder!

Today on #RareDiseaseDay, we are reminded of the profound impact our work can have on real lives. It’s a powerful reason behind everything we do. Thank you, #Everlum, for this beautiful reminder!
bit.bio (@bitbio) 's Twitter Profile Photo

NEW ioCELLS™ ALERT! #bitbio expands CRISPR-Ready ioCells range, enabling precise gene perturbation in human iPSC-derived cells. Read the press release: hubs.ly/Q038_G9S0 #CRISPR #GeneEditing

NEW ioCELLS™ ALERT! #bitbio expands CRISPR-Ready ioCells range, enabling precise gene perturbation in human iPSC-derived cells. 

Read the press release: hubs.ly/Q038_G9S0

#CRISPR #GeneEditing
bit.bio (@bitbio) 's Twitter Profile Photo

Join us for an insightful #webinar on real-world applications of our deterministically programmed human iPSC-derived #ioCells across key stages of early-stage #DrugDiscovery. hubs.ly/Q039mMHG0

Join us for an insightful #webinar on real-world applications of our deterministically programmed human iPSC-derived #ioCells across key stages of early-stage #DrugDiscovery. hubs.ly/Q039mMHG0
bit.bio (@bitbio) 's Twitter Profile Photo

Science thrives on diverse perspectives! Today, on #InternationalWomensDay, we celebrate the brilliant, driven, and passionate women of #bit.bio for their dedication, expertise, and impact. #IWD2025 #WomenInScience #InternationalWomensDay

Science thrives on diverse perspectives! Today, on #InternationalWomensDay, we celebrate the brilliant, driven, and passionate women of #bit.bio for their dedication, expertise, and impact.

#IWD2025 #WomenInScience #InternationalWomensDay
bit.bio (@bitbio) 's Twitter Profile Photo

Team #bitbio took on the Cambridge Half Marathon this weekend! A huge well done to everyone who ran, cheered, and made this event such a great team effort! 👏💪 #CambridgeHalfMarathon #TeamBitBio #StrongerTogether

Team #bitbio took on the Cambridge Half Marathon this weekend! A huge well done to everyone who ran, cheered, and made this event such a great team effort! 👏💪 

#CambridgeHalfMarathon #TeamBitBio #StrongerTogether
bit.bio (@bitbio) 's Twitter Profile Photo

Attending #SOT2025 in Orlando? We are keen to discuss the latest data on deterministically programmed human iPSC-derived hepatocytes and how these cells can support toxicology studies. Book a meeting here: hubs.ly/Q03bsH4M0

Attending #SOT2025 in Orlando? We are keen to discuss the latest data on deterministically programmed human iPSC-derived hepatocytes and how these cells can support toxicology studies.
Book a meeting here: hubs.ly/Q03bsH4M0
bit.bio (@bitbio) 's Twitter Profile Photo

Happy St. Patrick's Day! 🍀 GFP ioMicroglia are engineered with built-in green fluorescence - helping you visualise, track, and isolate microglia in complex co-cultures. hubs.ly/Q03b--TJ0 #StPatricksDay #GFP #ioMicroglia #iPSC #Neuroscience #CellBiology #optiox #ioCells

bit.bio (@bitbio) 's Twitter Profile Photo

Proud to be named for the second year in a row as one of the UK & Ireland’s fastest-growing startups on the Sifted 100 list. hubs.ly/Q03dDlWw0 #SiftedLeaderboards #Sifted100 #ioCells #optiox

Proud to be named for the second year in a row as one of the UK &amp; Ireland’s fastest-growing startups on the Sifted 100 list. hubs.ly/Q03dDlWw0  

#SiftedLeaderboards #Sifted100 #ioCells #optiox
bit.bio (@bitbio) 's Twitter Profile Photo

Special issue of Science Advances highlighting some of the most exciting areas of discovery in women’s health science. hubs.ly/Q03gngqs0 #WomensHealth #WomenInScience #HealthResearch #ScienceAdvances #HealthEquity

Special issue of Science Advances highlighting some of the most exciting areas of discovery in women’s health science. 
hubs.ly/Q03gngqs0

#WomensHealth #WomenInScience #HealthResearch #ScienceAdvances #HealthEquity
bit.bio (@bitbio) 's Twitter Profile Photo

A significant shift in drug development is underway. Read our perspective > hubs.ly/Q03hcW9H0 #DrugDiscovery #FDA #iPSC #ioCells #optiox

A significant shift in drug development is underway. Read our perspective &gt; hubs.ly/Q03hcW9H0

#DrugDiscovery #FDA #iPSC #ioCells #optiox